Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology.

Saved in:
Bibliographic Details
Title: Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology.
Authors: Lontos K; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA.; Division of Hematology/Oncology, UPMC, Pittsburgh, PA, USA., Wang Y; School of Medicine, Tsinghua University, Beijing, Peking, China., Colbert M; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Kumar A; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Joshi S; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Philbin M; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Wang Y; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA.; School of Medicine, Tsinghua University, Beijing, Peking, China., Frisch A; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA.; Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Lohmueller J; Department of Surgery, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Rivadeneira DB; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Delgoffe GM; Tumor Microenvironment Center, Department of Immunology, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA.
Source: Oncoimmunology [Oncoimmunology] 2022 Oct 18; Vol. 11 (1), pp. 2131229. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2131229